Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

27-01-2024 | Prostate Cancer | Editorial

The EANM Focus 5 consensus on ‘molecular imaging and theranostics in prostate cancer’: the future begins today

Authors: Daniela-Elena Oprea-Lager, Steven MacLennan, Rudi Dierckx, Stefano Fanti

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 5/2024

Excerpt

After three years of COVID-pandemic, and in that setting an once postponed and eventually cancelled European Association of Nuclear medicine (EANM) Focus 4 on molecular imaging and therapy in haematological tumours [1], the Nuclear Medicine community felt the longing for a live consensus meeting, with multidisciplinary stakeholders. As the clinical evidence was pointing to Theranostics in prostate cancer to be the most dynamic and rapidly evolving field in Oncology in the past 5 years, the choice for a new focus topic was obvious. …

Nanni C, Kobe C, Baeßler B, Baues C, Boellaard R, et al. European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours. Lancet Haematol. 2023;10(5):e367–81. https://doi.org/10.1016/S2352-3026(23)00030-3.CrossRefPubMed

Fanti S, Minozzi S, Antoch G, Banks I, Briganti A, et al. Consensus on molecular imaging and theranostics in prostate cancer. Consensus on molecular imaging and theranostics in prostate cancer. Lancet Oncol. 2018;19(12):e696–708. https://doi.org/10.1016/S1470-2045(18)30604-1.CrossRefPubMed

Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, et al. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer’s disease and other dementias. Lancet Neurol. 2020;19:951–62. https://doi.org/10.1016/S1474-4422(20)30314-8.CrossRefPubMed

Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, et al. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. EJC. 2021;146:56–73. https://doi.org/10.1016/j.ejca.2021.01.008.CrossRef

Oprea-Lager DE, MacLennan S, Bjartell A, Alberto Briganti A, Burger IA, et al. European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer. Eur Urol. 2023;S0302–2838(23):03092. https://doi.org/10.1016/j.eururo.2023.09.003.CrossRef

Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https://doi.org/10.1016/j.jbi.2019.103208.CrossRefPubMedPubMedCentral

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81. https://doi.org/10.1016/j.jbi.2008.08.010.CrossRefPubMed

Turpin A, Girard E, Baillet C, et al. Imaging for metastasis in prostate cancer: a review of the literature. Front Oncol. 2020;10:55. https://doi.org/10.3389/fonc.2020.00055.CrossRefPubMedPubMedCentral

Huo H, Shen S, He D, Liu B, Yang F. Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-tohead comparison studies. Prostate Cancer Prostatic Dis. 2023;26:16–24. https://doi.org/10.1038/s41391-022-00581-y.CrossRefPubMed

10.

Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTROESUR- SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79:243–62. https://doi.org/10.1016/j.eururo.2020.09.042.CrossRefPubMed

11.

Cornford P, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTROESUR- SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2021;79:263–82. https://doi.org/10.1016/j.eururo.2020.09.046.CrossRefPubMed

Title: The EANM Focus 5 consensus on ‘molecular imaging and theranostics in prostate cancer’: the future begins today
Authors: Daniela-Elena Oprea-Lager
Steven MacLennan
Rudi Dierckx
Stefano Fanti
Publication date: 27-01-2024
Publisher: Springer Berlin Heidelberg
Keywords: Prostate Cancer
Prostate Cancer
Molecular Imaging
Positron Emission Tomography
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2024
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-023-06552-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The EANM Focus 5 consensus on ‘molecular imaging and theranostics in prostate cancer’: the future begins today

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2024

FDG-PET/CT for investigation of pyrexia of unknown origin: a cost of illness analysis

Performance of [18F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent disease

The clinical acceptability of short versus long duration acquisitions for head and neck cancer using long-axial field-of-view PET/CT: a retrospective evaluation

Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptance

Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance

A. Zaheer, S.P. Raman, M.L. Rosado-de-Christenson, S. Martínez-Jiménez, S.H. Garrana, G. Fananapazir, D. Rogers, B.R. Foster: Imaging Anatomy: Chest, Abdomen, Pelvis, 3rd Edition